The case of a patient admitted with thrombotic thrombocytopenic purpura nine years after developing systemic lupus erythematosus (SLE) is reported. Thrombotic thrombocytopenic purpura associated with SLE has been described on other occasions, but in most patients the diagnosis of SLE precedes that ofthrombotic thrombocytopenic purpura.
Case report A 30 year old woman with no relevant medical history was admitted in January 1980 with general weakness, headache, jaundice, and petechiae. Physical examination also revealed skin amd mucous membrane pallor and hepatosplenomegaly.
A chest radiograph was normal. Laboratory data included severe anaemia with haemoglobin 70 g/l (normal <120 g/l), packed cell volume 0-2, abundant schistocytes, platelet count 17x 109/1 (normal 150-450x 109/1), direct bilirubin 136-8 ltmol/l (normal Triggering factors of thrombotic thrombocytopenic purpura include toxic agents, infections and drugs, although in most patients (90%) there is no apparent cause.' The association ofSLE and thrombotic thrombocytopenic purpura is rare. In the review of Ridolfi and Bell' of 250 patients with thrombotic thrombocytopenic purpura, only three met the presently accepted criteria for SLE.'6 Isolated patients with thrombotic thrombocytopenic purpura and SLE were later described.3 >12 In the series of Levine and Shearn,7 34 of 151 patients (23%) presented signs and symptoms suggestive of SLE. Clinical information available on these patients was incomplete and did not fulfil the American Rheumatism Association 1982 revised criteria for the diagnosis of SLE. 6 There are only three reported patients in whom the diagnosis of thrombotic thrombocytopenic purpura preceded the development of SLE.2 13 However, the diagnosis of SLE in these patients was based on pathological findings (LibmanSacks endocarditis, glomerulosclerosis, periadventitial splenic fibrosis), which suggested a 'lupus-type' disease; the strict application of present criteria places the diagnosis in doubt. On her second admission, our patient, apart from presenting no signs of thrombotic thrombocytopenic purpura, fulfilled sufficient criteria for the diagnosis of SLE (arthritis, leucopenia, diffuse proliferative glomerulonephritis, high antinuclear antibody titres and increased antibodies to double stranded DNA).
To establish a pathogenic relation between thrombotic thrombocytopenic purpura and SLE, various hypotheses have been suggested; however, the precise mechanism is still to be defined. Patients with SLE may present alterations of coagulation and thus be at greater risk of thrombosis.'7 1 Some patients with SLE who developed thrombotic thrombocytopenic purpura had a previous history of thrombophlebitis.5" On the other hand, an immunological connection between the two diseases has not been identified, as patients with SLE who present with thrombotic thrombocytopenic purpura during a clinical or immunological flare of their disease have also been described.5 "
The development of thrombotic thrombocytopenic purpura during remission of SLE has also been reported. 4 
